Advancing Oncology Supportive Care
Through
Science, Simplicity & Empathy.
Discover our mission
Advancing Oncology Supportive Care
At Tarian Pharma, we believe that supportive care deserves the same ambition as primary treatment. For too long, skin toxicities have been accepted as unavoidable collateral damage, discomfort patients must endure in silence. We see things differently.
Our ambition is clear: to transform skin toxicities care in oncology through proactive, science-driven supportive care.
We believe skin toxicities should not compromise treatment continuity or force patients away from life-saving cancer therapies.
We aim for a future where cancer treatment does not come at the cost of pain, or isolation.
Our ambition is to make holistic cancer care the standard, addressing both the disease and the physical and emotional impact of cancer treatment.
Skin Protection & Treatment Continuity in Oncology
We concentrate our efforts on one urgent, unmet need: treatment-related skin toxicities that disrupt care, reduce quality of life, and weaken treatment adherence.
Our focus is targeted. We are developing one differentiated topical supportive care candidate designed to:
- Prevent cutaneous toxicities
- Support treatment continuity
- Reduce treatment interruptions and patient distress
Every clinical choice, every formulation, every study serves one single goal: protecting patients so they can continue their treatment as safely and fully as possible.
